Cognitive · Cognitive peptide (research)
Semax
- Drug class
- Cognitive peptide (research)
- Status
- Compounded (503A)
- Reviewed
- 2026-06-01 · Dr. Ana Lisa Carr, MD
What Semax is studied for
- Focus & attention (research)
- BDNF support (research)
- Neuroprotection (research)
Mechanism of action
Semax is being studied in the cognitive category. Nootropic supporting BDNF, focus, and neuroprotection. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is Semax?
Semax is a cognitive peptide. Nootropic supporting BDNF, focus, and neuroprotection.
What is Semax studied for?
Published research has examined Semax for focus & attention, bdnf support, neuroprotection. Human clinical evidence varies by indication.
Is Semax FDA-approved?
No. Semax is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is Semax used in research?
Protocols vary by study. Semax is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for Semax is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.
